Trump Administration Announces Tariffs on Generic Drugs
The White House has announced a new policy to impose tariffs on generic drugs. The tariffs will be implemented in phases, with drugmakers given two years to shift production to the U.S.
The Trump Administration has unveiled a plan to impose tariffs on generic drugs in an effort to boost U.S. production. The policy will be implemented under Section 232 authority, which allows the president to impose tariffs for national security reasons.
The plan gives drugmakers two years to shift their generic drug production to the U.S. before the tariffs rise. This move is intended to encourage companies to bring their manufacturing operations back to the United States.
The use of Section 232 authority for this policy is notable, as it is typically used for national security purposes. In this case, the administration is using it to promote domestic production of generic drugs.
Go Deeper
What is Section 232 authority?
Section 232 authority is a law that allows the president to impose tariffs on imports for national security reasons. It has been used in the past to impose tariffs on steel and aluminum imports.
How will the tariffs be implemented?
The tariffs will be implemented in phases, with drugmakers given two years to shift their generic drug production to the U.S. before the tariffs rise.
What is the goal of the policy?
The goal of the policy is to boost U.S. production of generic drugs by encouraging companies to bring their manufacturing operations back to the United States.
How will the policy affect drugmakers?
The policy will give drugmakers two years to shift their production to the U.S. before facing tariffs. This may require significant investments in new manufacturing facilities and equipment.
What types of drugs will be affected by the tariffs?
The tariffs will apply to generic drugs, which are lower-cost versions of brand-name drugs. The policy is intended to promote domestic production of these drugs.
More business
Barclays Reports 18% Profit Increase
Barclays has announced an 18% rise in profits. The bank has also lifted its income guidance.
Aug 4businessTrainline Raises Guidance for Second Time in 2024
Trainline has increased its guidance for the second time this year. The company's decision reflects its current performance and outlook.
Aug 4businessPlus500 Quarterly Revenue Rises 11%
Plus500's quarterly revenue increased by 11%. The company now expects to meet its expectations for the period.
Aug 4